ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
ESCALON MEDICAL CORP
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026
- Market cap
- $2.72M
- P/E (TTM)
- 0.7
- Dividend yield
- –
ESCALON MEDICAL CORP revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2014 | FY2013 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $12.05M | $11.98M | – | – | – | – | – | – | – | – | 100.0% | +0.5% |
| Corporate [Member] | – | – | – | – | – | – | – | – | $0 | $0 | – | – |
| Sonomed-Escalon [Member] | – | – | – | – | – | – | – | – | $5.42M | $4.71M | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2014 | FY2013 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate [Member] | – | – | – | – | – | – | – | – | -$415.00K | -$419.00K | – |
| Sonomed-Escalon [Member] | – | – | – | – | – | – | – | – | $58.00K | -$813.00K | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2014 | FY2013 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $11.51M | $11.42M | $11.56M | $9.98M | $9.55M | $8.44M | $8.71M | $10.55M | – | – | 95.6% | +0.8% |
| Service [Member] | $531.81K | $556.61K | $624.31K | $722.73K | $924.01K | $962.36K | $919.51K | $852.00K | – | – | 4.4% | -4.5% |
By region
From the segment and revenue-disaggregation notes of Escalon Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.